Important Lessons Learned From Eliminating Race-Based Medicine in Kidney Care-Praxis and Policy Matter [0.03%]
从肾脏护理中消除基于种族的医学所得到的重要教训-实践和政策很重要
L Ebony Boulware,Dinushika Mohottige,Tanjala S Purnell
L Ebony Boulware
Cost-Related Medication Nonadherence After the Inflation Reduction Act [0.03%]
《通胀削减法案》后与成本相关的药物不依从性
Lucas X Marinacci,Stephen Mein,Benjamin N Rome et al.
Lucas X Marinacci et al.
Importance: High prescription drug costs are a pressing national concern and contribute to medication nonadherence and poor health outcomes. The Inflation Reduction Act (IRA) introduced sweeping reforms to improve medicat...
Evaluating Medicare's Prior Authorization Model Design-WISeR on Waste [0.03%]
评价医疗充公的预先审批模型设计-WISeR在浪费评估中的应用
Jacob T Kannarkat,Varun Thachil,Joseph T Kannarkat et al.
Jacob T Kannarkat et al.
Mohammad Jay
Mohammad Jay
Cost-Related Medication Nonadherence Before and After the 2024 Inflation Reduction Act Provisions [0.03%]
2024年《抑制通胀法案》生效前后的与成本相关的药物依从性问题
Anna Hung,Timothy S Anderson
Anna Hung
Wait Time Modifications for Black Transplant Candidates Affected by Race-Based Kidney Function Estimation [0.03%]
基于种族的肾脏功能估计对黑人移植供者等待时间修改的影响
Rohan Khazanchi,Aaron Fleishman,Nwamaka D Eneanya et al.
Rohan Khazanchi et al.
Importance: Until 2021, national guidelines upheld race-based equations that assigned higher kidney function estimates to Black patients, delaying subspecialist referral and transplant waitlisting. In 2023, the Organ Proc...
Error in Figure 1 [0.03%]
图1有误
Published Erratum
JAMA internal medicine. 2026 Mar 9:e260434. DOI:10.1001/jamainternmed.2026.0434 2026
Applying the Cardiff Model for Violence Prevention in the US-An Opportunity for Action Now [0.03%]
在美国应用加的夫城市暴力预防模式-立即行动的机会
Thomas R Simon,Daniel T Wu,Stephen W Hargarten
Thomas R Simon
Michael D Ranando,Joshua D Wallach,Joseph S Ross et al.
Michael D Ranando et al.
Teva D Brender
Teva D Brender